Kontaktujte nás | Jazyk: čeština English
| dc.title | What is uric acid concentration in urine in patients with uric acid kidney stones? - a case study | en |
| dc.contributor.author | Šálek, Tomáš | |
| dc.contributor.author | Musil, Pavel | |
| dc.contributor.author | Zlatníková, Irena | |
| dc.relation.ispartof | Biochemia Medica | |
| dc.identifier.issn | 1330-0962 Scopus Sources, Sherpa/RoMEO, JCR | |
| dc.identifier.issn | 1846-7482 Scopus Sources, Sherpa/RoMEO, JCR | |
| dc.date.issued | 2025 | |
| utb.relation.volume | 35 | |
| utb.relation.issue | 3 | |
| dc.citation.spage | 31001 | |
| dc.type | article | |
| dc.language.iso | en | |
| dc.identifier.doi | 10.11613/BM.2025.031001 | |
| dc.relation.uri | https://www.biochemia-medica.com/en/journal/35/3/10.11613/BM.2025.031001/fullArticle | |
| dc.relation.uri | https://www.biochemia-medica.com/assets/images/upload/xml_tif/bm-35-3-031001.pdf | |
| dc.subject | nephrolithiasis | en |
| dc.subject | uric acid | en |
| dc.subject | urine specimen collection | en |
| dc.subject | urine | en |
| dc.subject | specimen preservation | en |
| dc.subject | citrate potassium | en |
| dc.subject | potassium citrate | en |
| dc.subject | case report | en |
| dc.subject | drug therapy | en |
| dc.subject | human | en |
| dc.subject | male | en |
| dc.subject | middle aged | en |
| dc.subject | pH | en |
| dc.subject | humans | en |
| dc.subject | hydrogen-ion concentration | en |
| dc.subject | kidney calculi | en |
| dc.subject | malepotassium citrate | en |
| dc.description.abstract | This case report describes a patient with uric acid kidney stones. Alkalization therapy using mainly potassium citrate is the first-choice treatment. When hyperuricosuria > 4 mmol/24 hours is present, xanthine oxidase inhibitors are added. It implies that accurate urine uric acid measurement is of high importance. Uric acid was measured in a 24-hour collection and a second-morning sample. Urine uric acid was measured after sample alkalization to pH > 6.5 and heating to 56 °C for 10 minutes, and for educational reasons without sample treatment. The uric acid excretion in the sample without alkalization in the 24-hour collection was 2.436 mmol, after alkalization, the excretion was 4.650 mmol/24 hours. Sample alkalization led to a prescription for xanthine oxidase inhibitor medication that is indicated as the second-line therapy when hyperuricosuria > 4 mmol/24 hours is present. This case study shows how the correct preanalytical phase is essential for medical decision-making. | en |
| utb.faculty | Faculty of Humanities | |
| dc.identifier.uri | http://hdl.handle.net/10563/1012525 | |
| utb.identifier.obdid | 43886733 | |
| utb.identifier.scopus | 2-s2.0-105013687779 | |
| utb.identifier.wok | 001615200300006 | |
| utb.identifier.pubmed | 40822842 | |
| utb.source | j-scopus | |
| dc.date.accessioned | 2025-10-16T07:25:46Z | |
| dc.date.available | 2025-10-16T07:25:46Z | |
| dc.rights | Attribution 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.rights.access | openAccess | |
| utb.ou | Department of Health Care Sciences | |
| utb.contributor.internalauthor | Šálek, Tomáš | |
| utb.fulltext.sponsorship | - | |
| utb.wos.affiliation | [Salek, Tomas; Musil, Pavel; Zlatnikova, Irena] Tomas Bata Hosp Zlin, Dept Clin Biochem & Pharmacol, Zlin, Czech Republic; [Salek, Tomas] Tomas Bata Univ Zlin, Fac Humanities, Dept Hlth Care Sci, Zlin, Czech Republic | |
| utb.scopus.affiliation | Šálek T., Department of Clinical Biochemistry and Pharmacology, Tomas Bata Hospital in Zlín, Zlín, Czech Republic, Department of Health Care Sciences, Faculty of Humanities, Tomas Bata University in Zlín, Zlín, Czech Republic; Musil P., Department of Clinical Biochemistry and Pharmacology, Tomas Bata Hospital in Zlín, Zlín, Czech Republic; Zlatníková I., Department of Clinical Biochemistry and Pharmacology, Tomas Bata Hospital in Zlín, Zlín, Czech Republic | |
| utb.fulltext.projects | - |